These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

561 related items for PubMed ID: 12778481

  • 1. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells.
    Hartmann G, Battiany J, Poeck H, Wagner M, Kerkmann M, Lubenow N, Rothenfusser S, Endres S.
    Eur J Immunol; 2003 Jun; 33(6):1633-41. PubMed ID: 12778481
    [Abstract] [Full Text] [Related]

  • 2. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.
    Kandimalla ER, Bhagat L, Li Y, Yu D, Wang D, Cong YP, Song SS, Tang JX, Sullivan T, Agrawal S.
    Proc Natl Acad Sci U S A; 2005 May 10; 102(19):6925-30. PubMed ID: 15860583
    [Abstract] [Full Text] [Related]

  • 3. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides.
    Gantner F, Hermann P, Nakashima K, Matsukawa S, Sakai K, Bacon KB.
    Eur J Immunol; 2003 Jun 10; 33(6):1576-85. PubMed ID: 12778475
    [Abstract] [Full Text] [Related]

  • 4. Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand.
    Marshall JD, Heeke DS, Gesner ML, Livingston B, Van Nest G.
    J Leukoc Biol; 2007 Sep 10; 82(3):497-508. PubMed ID: 17565046
    [Abstract] [Full Text] [Related]

  • 5. Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities.
    Vollmer J, Weeratna R, Payette P, Jurk M, Schetter C, Laucht M, Wader T, Tluk S, Liu M, Davis HL, Krieg AM.
    Eur J Immunol; 2004 Jan 10; 34(1):251-62. PubMed ID: 14971051
    [Abstract] [Full Text] [Related]

  • 6. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
    Vollmer J, Weeratna RD, Jurk M, Davis HL, Schetter C, Wüllner M, Wader T, Liu M, Kritzler A, Krieg AM.
    J Leukoc Biol; 2004 Sep 10; 76(3):585-93. PubMed ID: 15218053
    [Abstract] [Full Text] [Related]

  • 7. CpG ODN enhance antigen-specific NKT cell activation via plasmacytoid dendritic cells.
    Marschner A, Rothenfusser S, Hornung V, Prell D, Krug A, Kerkmann M, Wellisch D, Poeck H, Greinacher A, Giese T, Endres S, Hartmann G.
    Eur J Immunol; 2005 Aug 10; 35(8):2347-57. PubMed ID: 16025562
    [Abstract] [Full Text] [Related]

  • 8. A minimal human immunostimulatory CpG motif that potently induces IFN-gamma and IFN-alpha production.
    Fearon K, Marshall JD, Abbate C, Subramanian S, Yee P, Gregorio J, Teshima G, Ott G, Tuck S, Van Nest G, Coffman RL.
    Eur J Immunol; 2003 Aug 10; 33(8):2114-22. PubMed ID: 12884285
    [Abstract] [Full Text] [Related]

  • 9. Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation.
    Guiducci C, Ott G, Chan JH, Damon E, Calacsan C, Matray T, Lee KD, Coffman RL, Barrat FJ.
    J Exp Med; 2006 Aug 07; 203(8):1999-2008. PubMed ID: 16864658
    [Abstract] [Full Text] [Related]

  • 10. Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions.
    Marshall JD, Fearon K, Abbate C, Subramanian S, Yee P, Gregorio J, Coffman RL, Van Nest G.
    J Leukoc Biol; 2003 Jun 07; 73(6):781-92. PubMed ID: 12773511
    [Abstract] [Full Text] [Related]

  • 11. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction.
    Honda K, Ohba Y, Yanai H, Negishi H, Mizutani T, Takaoka A, Taya C, Taniguchi T.
    Nature; 2005 Apr 21; 434(7036):1035-40. PubMed ID: 15815647
    [Abstract] [Full Text] [Related]

  • 12. IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production.
    Giordani L, Sanchez M, Libri I, Quaranta MG, Mattioli B, Viora M.
    J Leukoc Biol; 2009 Aug 21; 86(2):261-71. PubMed ID: 19401392
    [Abstract] [Full Text] [Related]

  • 13. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
    Merlo A, Calcaterra C, Mènard S, Balsari A.
    J Leukoc Biol; 2007 Sep 21; 82(3):509-18. PubMed ID: 17586660
    [Abstract] [Full Text] [Related]

  • 14. Murine thymic plasmacytoid dendritic cells.
    Okada T, Lian ZX, Naiki M, Ansari AA, Ikehara S, Gershwin ME.
    Eur J Immunol; 2003 Apr 21; 33(4):1012-9. PubMed ID: 12672067
    [Abstract] [Full Text] [Related]

  • 15. CpG-B ODNs potently induce low levels of IFN-alphabeta and induce IFN-alphabeta-dependent MHC-I cross-presentation in DCs as effectively as CpG-A and CpG-C ODNs.
    Gray RC, Kuchtey J, Harding CV.
    J Leukoc Biol; 2007 Apr 21; 81(4):1075-85. PubMed ID: 17227820
    [Abstract] [Full Text] [Related]

  • 16. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells.
    Krug A, Rothenfusser S, Hornung V, Jahrsdörfer B, Blackwell S, Ballas ZK, Endres S, Krieg AM, Hartmann G.
    Eur J Immunol; 2001 Jul 21; 31(7):2154-63. PubMed ID: 11449369
    [Abstract] [Full Text] [Related]

  • 17. Impact of secondary structure of toll-like receptor 9 agonists on interferon alpha induction.
    Yu D, Putta MR, Bhagat L, Dai M, Wang D, Trombino AF, Sullivan T, Kandimalla ER, Agrawal S.
    Antimicrob Agents Chemother; 2008 Dec 21; 52(12):4320-5. PubMed ID: 18852281
    [Abstract] [Full Text] [Related]

  • 18. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells.
    Kerkmann M, Rothenfusser S, Hornung V, Towarowski A, Wagner M, Sarris A, Giese T, Endres S, Hartmann G.
    J Immunol; 2003 May 01; 170(9):4465-74. PubMed ID: 12707322
    [Abstract] [Full Text] [Related]

  • 19. The immunostimulatory activity of CpG oligonucleotides on microglial N9 cells is affected by a polyguanosine motif.
    Zhang Z, Guo K, Schluesener HJ.
    J Neuroimmunol; 2005 Apr 01; 161(1-2):68-77. PubMed ID: 15748945
    [Abstract] [Full Text] [Related]

  • 20. CpG motif-independent activation of TLR9 upon endosomal translocation of "natural" phosphodiester DNA.
    Yasuda K, Rutz M, Schlatter B, Metzger J, Luppa PB, Schmitz F, Haas T, Heit A, Bauer S, Wagner H.
    Eur J Immunol; 2006 Feb 01; 36(2):431-6. PubMed ID: 16421948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.